| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $15.9M | -10.4% |
| SG&A Expense | $9.1M | +3.8% |
| Operating Income | -$25.1M | +5.8% |
| Pre-tax Income | -$33.6M | -28.8% |
| Income Tax | $0 | — |
| Net Income | -$33.6M | -54.2% |
| EPS (Basic) | -$28.42 | -349.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.9M | +107.5% |
| Current Assets | $9.7M | +86.5% |
| Total Assets | $22.1M | +30.7% |
| Current Liabilities | $6.9M | +27.9% |
| Total Liabilities | $7.1M | -35.0% |
| Stockholders' Equity | $15.0M | +151.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$22.7M | +4.7% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $27.3M | +488.7% |
| Free Cash Flow | -$22.7M | +4.8% |